C12N 2720/10041
Use of virus, viral particle or viral elements as a vector
C12N2720/10041 (Use of virus, viral particle or viral elements as a vector) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 6
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 24 May 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Subgroups
Granted patents
- C12N 2720/10043Viral genome or elements thereof as genetic vectorIndexing code2
- C12N 2720/10044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
- C12N 2720/10042Virus or viral particle as vehicleIndexing code0
- C12N 2720/10045Special targeting system for viral vectorsIndexing code0
Recent patents
- IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same24 May 2016US 9,345,760 B2Advanced Bionutrition Corporation
- Compositions and methods for the treatment of viral hepatitis19 Mar 2013US 8,398,969 B2HepC Biotechnológiai Kutató és Fejlesztö Kft.
- Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts14 Aug 2001US 6,274,147 B1University of Maryland Biotechnology Institute
- Hvt aiv vectors and uses thereof27 Feb 2025US 2025/0064917 A1Boehringer Ingelheim Vetmedica GmbH
- Oncolytic virus based cancer therapy25 Jul 2024US 2024/0245739 A1
- Combination of viral superinfection therapy with subthreshold doses of nivolumab plus ipilimumab in chronic HBV patients16 Dec 2021US 2021/0386804 A1
- Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same23 Oct 2014US 2014/0314858 A1Advanced Bionutrition Corporation
- Compositions and methods for the treatment of viral hepatitis26 Nov 2009US 2009/0291063 A1HepC Biotechnológiai Kutató és Fejlesztö Kft.
Most cited
By later US patents